Tag: <span>JAK indication</span>

Jason Mast Editor Over the last decade, drug­mak­ers have proven JAK in­hibitors can treat a smat­ter­ing of im­mune-re­lat­ed dis­eases rang­ing from rheuma­toid arthri­tis to Covid-19. Now Eli Lil­ly has pulled out a new one. Lil­ly and its biotech part­ner In­cyte an­nounced Wednes­day that their JAK in­hibitor baric­i­tinib ef­fec­tive­ly re­grew pa­tients’ hair in a Phase III...